Alphabet – 52 Year Dividend History | GOOG Historical dividend payout and yield for Alphabet (GOOG) since 1971. The current TTM dividend payout for Alphabet (GOOG) as of May 04, 2023 is $0.00, The current dividend yield for Alphabet as of May 04, 2023 is 0.00%,
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $1359.079B | $282.836B | ||
| Alphabet Inc. is engaged in technology business. The Company provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce and hardware products through its subsidiaries. Alphabet Inc., formerly known as Google Inc., is headquartered in Mountain View, California. |
table>
Alphabet – 52 Year Dividend History | GOOG
Will GE HealthCare declare a dividend?
GE Healthcare Technologies Inc. Declares Dividend for the First Quarter of 2023, Payable on June 15, 2023. GE HealthCare declared a cash dividend of $0.03 per share on the Company’s common stock for the first quarter of 2023.
Will GE pay a dividend in 2023?
GE Board of Directors Authorizes Regular Quarterly Dividend BOSTON, Mass.—February 10, 2023—The Board of Directors of GE (NYSE: GE) today declared a $0.08 per share dividend on the outstanding common stock of the Company. The dividend is payable April 25, 2023, to shareholders of record at the close of business on March 7, 2023.
- The ex-dividend date is March 6, 2023.
- About GE GE (NYSE:GE) rises to the challenge of building a world that works.
- For more than 130 years, GE has invented the future of industry, and today the company’s dedicated team, leading technology, and global reach and capabilities help the world work more efficiently, reliably, and safely.
GE’s people are diverse and dedicated, operating with the highest level of integrity and focus to fulfill GE’s mission and deliver for its customers. GE’s Investor Relations website at and our corporate blog at and @GE_Reports on Twitter, as well as GE’s Facebook page and Twitter accounts, contain a significant amount of information about GE, including financial and other information for investors.
Will GE shareholders get GE HealthCare stock?
josefkubes Last week, General Electric ( NYSE: GE ) completed the long-anticipated spin-off of its healthcare division, GE HealthCare Technologies ( NASDAQ: GEHC ). This is a concrete step toward CEO Larry Culp’s efforts to transform GE from a conglomerate into distinct and more successful individual businesses.
- Culp had a highly successful run as the leader of industrial giant Danaher ( DHR ), frequently buying and selling assets of that company to optimize its capital structure and deliver superior shareholder returns.
- GE has been divesting assets for many years.
- It had already gotten rid of GE Capital, Baker Hughes, and numerous other smaller assets.2021 brought the sale of the company’s large aircraft leasing operations.
And now, with those steps out of the way, GE has continued to the bigger move, separating its remaining core pieces into three standalone companies. With the successful launch of GE HealthCare, the restructuring plan is well on its way to finally being completed.
What is the projected stock price for Gehc?
Stock Price Forecast – The 4 analysts offering 12-month price forecasts for GE Healthcare Technologies Inc have a median target of 92.00, with a high estimate of 95.00 and a low estimate of 86.00. The median estimate represents a +16.38% increase from the last price of 79.05.
What is the dividend date for GE?
GE Dividend History
| Ex/EFF DATE | TYPE | CASH AMOUNT |
|---|---|---|
| 06/27/2022 | CASH | $0.08 |
| 03/07/2022 | CASH | $0.08 |
| 12/20/2021 | CASH | $0.08 |
| 09/24/2021 | CASH | $0.08 |
Will GE spin off HealthCare?
S pin-off of GE HealthCare creates global leader in Precision Care GE HealthCare to begin trading on The Nasdaq Stock Market LLC (“Nasdaq”) on January 4, 2023, under ticker “GEHC”; GE will continue to trade on New York Stock Exchange (“NYSE”) under ticker “GE” GE remains on track to launch GE Aerospace and GE Vernova as independent, industry-leading, investment grade companies in early 2024
BOSTON – January 4, 2023 – GE (NYSE: GE) announced that it has completed the separation of its healthcare business, launching GE HealthCare Technologies Inc. (“GE HealthCare”), a global leader in Precision Care. Starting today, January 4, 2023, GE HealthCare will trade on Nasdaq under the ticker symbol “GEHC”.H.
- Lawrence Culp Jr., Chairman and CEO, GE and CEO, GE Aerospace, said, “The successful spin-off of GE HealthCare marks a pivotal moment in our transformation into three independent companies focused on critical, growing sectors.
- I am tremendously proud of the GE and GE HealthCare teams for their work to prepare this great business to stand on its own as an industry-leading, investment grade company focused on Precision Care.” Culp continued, “We’re on track and confident in our plans to unleash the potential of GE Aerospace and GE Vernova as separate companies in early 2024.
These two global leaders are creating a smarter, more efficient future of flight and driving decarbonization to address the energy transition. With lean and innovation at our core, we could not be more excited about the future.” Holders of GE common stock received one share of GE HealthCare common stock for every three shares of GE common stock held.
- The distribution was part of a tax-free spin-off, resulting in tax efficiency for GE shareholders in the United States.
- GE is retaining approximately 19.9 percent of the shares of GE HealthCare common stock.
- Culp will serve as non-executive chairman of GE HealthCare.
- Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal counsel.
Evercore, Morgan Stanley, and PJT Partners were the lead financial advisors to GE on the transaction. GE also received legal advice from Gibson, Dunn & Crutcher LLP and DLA Piper and financial advice from BofA Securities, Citibank, and Goldman Sachs. For additional information, please visit GE’s “Spin-off Resources” page on GE’s investor relations website: https://www.ge.com/investor-relations/spinoff-resources.
Forward-Looking and Cautionary Statements This document contains forward-looking statements – that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain. For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, including (1) our success in executing and completing asset dispositions or other transactions, including our planned spin-off of our portfolio of energy businesses that are planned to be combined as GE Vernova (Renewable Energy, Power, Digital and Energy Financial Services), and sales of our equity ownership positions in Baker Hughes, AerCap and GE HealthCare, the timing of closing for such transactions, the ability to satisfy closing conditions, and the expected proceeds, consideration and benefits to GE; (2) changes in macroeconomic and market conditions and market volatility, including impacts related to the COVID-19 pandemic, risk of recession, inflation, supply chain constraints or disruptions, rising interest rates, the value of securities and other financial assets (including our equity ownership positions in Baker Hughes, AerCap and GE HealthCare), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our business operations, financial results and financial position and (3) our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the capital structures of the three public companies that we plan to form from our businesses, the timing and amount of dividends, share repurchases, organic investments, and other priorities, see https://www.ge.com/investor-relations/important-forward-looking-statement-information, as well as our SEC filings.
We do not undertake to update our forward-looking statements. GE’s portfolio of energy businesses For IR inquiries, please contact: Steve Winoker Vice President, Investor Relations GE +1 617 443 3400 For media inquiries, please contact: Whitney Mercer Senior Manager, Financial & Executive Communications GE 1 857 303 3079
Is GE a good long term buy?
Bottom line: GE stock is a buy. Over the long term, buying an index fund, such as SPDR S&P 500 (SPY), would have delivered safer, higher returns than GE stock. If you want to invest in a large-cap stock, IBD offers several strong ideas here.
Does GE stock have a future?
Stock Price Forecast – The 17 analysts offering 12-month price forecasts for General Electric Co have a median target of 109.00, with a high estimate of 120.00 and a low estimate of 90.00. The median estimate represents a +8.85% increase from the last price of 100.14.
What will GE stock be worth in 5 years?
GE stock price stood at $99.32 – According to the latest long-term forecast, GE price will hit $110 by the end of 2023 and then $150 by the end of 2024. GE will rise to $200 within the year of 2026, $250 in 2027 and $300 in 2032.
| Year | Mid-Year | Year-End | Tod/End,% |
| 2023 | $103.18 | $ 119.83 | +21% |
| 2024 | $123.96 | $ 151.85 | +53% |
| 2025 | $179.18 | $ 183.16 | +84% |
| 2026 | $206.71 | $ 218.23 | +120% |
| 2027 | $229.85 | $ 250.54 | +152% |
| 2028 | $251.75 | $ 257.06 | +159% |
| 2029 | $265.54 | $ 271.02 | +173% |
| 2030 | $276.73 | $ 282.68 | +185% |
| 2031 | $288.89 | $ 295.38 | +197% |
| 2032 | $302.17 | $ 309.28 | +211% |
| 2033 | $316.73 | $ 324.55 | +227% |
| 2034 | $332.77 | $ 341.41 | +244% |
Is GE HealthCare a good buy?
The financial health and growth prospects of GEHC, demonstrate its potential to outperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
Will GE stock survive?
In all of 2022, analysts now forecast GE earnings will jump 50% per share on roughly flat sales. They expect GE earnings to rise a further 71% in 2023 as revenue grows 9%. But they expect General Electric to surpass 2019 EPS of $5.20 only in 2024, FactSet says. Out of 22 analysts on Wall Street, 14 rate GE stock a buy.
How many GE HealthCare shares will I get?
If you owned GE common stock as of the close of business on December 16, 2022, the record date for the distribution, the shares of GE HealthCare common stock that you received in the spin-off were issued to your account as follows: i. Registered stockholders: If you owned your shares of GE common stock directly, either in book-entry form through an account at GE’s transfer agent (Equiniti Trust Company) and/or if you held paper stock certificates, you are a registered shareholder.
- In this case, the distribution agent credited the whole shares of common stock you received in the spin-off by way of direct registration in book-entry form to a new account with our transfer agent.
- Registration in book- entry form refers to a method of recording share ownership where no physical stock certificates are issued to stockholders, as will be the case in the spin-off.
You will be able to access information regarding your book-entry account for shares of our common stock at Shareowneronline.com or by calling Equiniti Trust Company at 1-800-786-2543 (toll free) or 1-651-450-4064. ii. “Street name” or beneficial stockholders: If you owned your shares of GE common stock beneficially through a bank, broker, or other nominee, the bank, broker, or other nominee holds the shares in “street name” and records your ownership on its books.
Is GE stock a buy or sell?
Bottom line: GE stock is a buy. Over the long term, buying an index fund, such as SPDR S&P 500 (SPY), would have delivered safer, higher returns than GE stock. If you want to invest in a large-cap stock, IBD offers several strong ideas here.
What is the price prediction for Gehc in 2025?
GE HealthCare Technologies Inc. Stock Prediction 2030 – In 2030, the GE HealthCare Technologies Inc. stock will reach $ 65.60 if it maintains its current 10-year average growth rate. If this GE HealthCare Technologies Inc. stock prediction for 2030 materializes, GEHC stock willgrow -16.97% from its current price.
- Based on data from May 05, 2023 at 16:36, the general GEHC stock forecast sentiment is bullish, with 14 technical analysis indicators signaling bullish signals, and 0 signaling bearish signals.
- GE HealthCare Technologies Inc.
- Stock forecast was last updated on May 05, 2023 at 16:36,
- Moving averages are a popular indicator in all financial markets.
The purpose of a moving average (MA) is to smooth price action over a certain amount of time. Moving averages are a lagging indicator which means they are based on previous price action. In the table below you can find two types of moving averages, simple moving average (SMA) and exponential moving average (EMA).
| Period | Value | Action |
|---|---|---|
| SMA 3 | $ 75.99 | BUY |
| SMA 5 | $ 76.18 | BUY |
| SMA 10 | $ 75.97 | BUY |
| SMA 21 | $ 73.86 | BUY |
| SMA 50 | $ 68.85 | BUY |
| SMA 100 | $ 0.00 | BUY |
| SMA 200 | $ 0.00 | BUY |
table>
table>
table>
table>
The GE HealthCare Technologies Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of GEHC stock is predicted to rise by 1.77% tomorrow and gain 11.71% in the next 7 days.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 10, 2023 | $ 75.88 | $ 74.50 | $ 75.51 | $ 74.97 | $ 3.39M |
| Mar 9, 2023 | $ 77.00 | $ 75.90 | $ 76.65 | $ 76.38 | $ 1.68M |
| Mar 8, 2023 | $ 76.25 | $ 76.10 | $ 76.75 | $ 76.63 | $ 1.64M |
The GE HealthCare Technologies Inc. stock forecast for tomorrow is $ 79.86, which would represent a 1.08% gain compared to the current price. In the next week, the price of GEHC is expected to increase by 1.25% and hit $ 80.00. As far as the long-term GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. stock prediction for 1 year from now: $ 74.93 (-5.17%) GE HealthCare Technologies Inc. stock forecast for 2025: $ 74.92 (-5.18%) GE HealthCare Technologies Inc. stock prediction for 2030: $ 65.60 (-16.97%)
According to our GE HealthCare Technologies Inc. stock prediction for 2025, GEHC stock will be priced at $ 74.92 in 2025. This forecast is based on the stock’s average growth over the past 10 years. According to our GE HealthCare Technologies Inc. stock prediction for 2030, GEHC stock will be priced at $ 65.60 in 2030.
This forecast is based on the stock’s average growth over the past 10 years. Based on our GE HealthCare Technologies Inc. stock forecast, GE HealthCare Technologies Inc. stock is currently not a good stock to buy. This is because the price of GE HealthCare Technologies Inc. stock is expected to increase by -5.17% in the next year.
The GE HealthCare Technologies Inc. stock price prediction for tomorrow is $ 79.86, based on the current market trends. According to the prediction, the price of GEHC stock will increase by 1.08% in the next day. The GE HealthCare Technologies Inc. stock price prediction for next week is $ 80.00, which would represent a 1.25% gain in the GEHC stock price.
- According to our prediction, GE HealthCare Technologies Inc.
- Stock will go up tomorrow.
- Based on the current trends, our prediction estimates that the price of GEHC stock will increase by 1.08% in the next day.
- Our prediction anticipates that GE HealthCare Technologies Inc.
- Stock will not go down tomorrow.
Our forecast estimates that GEHC will gain 1.08% in the next day and reach a price of $ 79.86. GE HealthCare Technologies Inc. stock traders use a variety of tools to make a prediction on which way the GEHC market is likely to head next. These tools can roughly be divided into indicators and chart patterns.
What is the future stock price for ARKG?
The average price target for ARKG is $50.52. This is based on 387 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $75.38,the lowest forecast is $32.67. The average price target represents N/A Increase from the current price of N/A.
Which stock has the highest dividend?
Pioneer Natural Resources –
Market value: $52.6 billion Dividend yield: 12.1% Analysts’ consensus recommendation: Buy
No stock in the S&P 500 has a higher dividend yield than independent oil and gas company Pioneer Natural Resources ( PXD (opens in new tab) ). And it’s no longer because of a depressed share price. PXD stock had lost as much as a fifth of its value for the year-to-date at one point in March, but then a couple of fortuitous catalysts came along.
- First, OPEC+ cut its oil production target in early April, which helped all oil and gas stocks.
- Then, about a week later, news broke that Exxon Mobil ( XOM (opens in new tab) ) held preliminary talks about a potential takeover of PXD.
- PXD stock was down just 2% on a price basis for the year-to-date through April 20, pushing the dividend yield down to 12.1% from an all-time peak of nearly 15% in mid-March.
And, for now at least, PXD’s dividends keep coming. For the first quarter of 2023, the company declared a quarterly base-plus-variable dividend of $5.58 per share, consisting of a $1.10 base dividend and $4.48 variable dividend. Wall Street was bullish on PXD stock’s potential to beat the broader market this year even before the company became an acquisition target.
What are the 3 dividend dates?
3 Dates to Remember if You Want A Cash Dividend – ACap Advisors & Accountants We all have important dates to remember in our lives such as birthdays and anniversaries. When it comes to investing for dividends, there are three key dates that everyone should memorize.
- The three dates are the date of declaration, date of record, and date of payment.
- Most investors buy stocks only for their cash dividends, this is especially true now because interest rates are so low and investors are hungry for yield.
- However, the next time you decide to buy a stock for its dividend, keep the following three dates in mind to ensure you get the cash you deserve.
Date of Declaration The date of declaration is when the company’s board of directors announces their intention to pay a cash dividend. Once declared, the company incurs a liability on their books to reflect the proposed dividend to shareholders. At the same meeting, the board of directors also announces the date of record and date of payment.
Date of Record (and ex-dividend date) The date of record is how the company determines which shareholders are entitled to the dividend. A company maintains a record of all their shareholders, unless the shares are held in street-name. Street-name means you own your shares through a brokerage account. In such cases, the company pays the broker and the broker deposits the cash dividend in your account.
The ex-dividend date is two days before the date of record. Investors who own the stock before the ex-dividend date are entitled to the dividend whereas investors who buy the stock on or after the ex-dividend date will not receive the dividend. As a result, the value of the stock declines on the ex-dividend date because the stock trades without the right to the dividend and the value of the company decreases because the dividend no longer belongs to the company.
Date of Payment This is the last date to remember for dividends because the date of payment is when you actually receives the cash dividend. Sometimes companies pay large special dividends (such as Microsoft in 2004) because they have excess cash on their books and they want to distribute it to shareholders.
You could potentially miss out on a cash dividend if you do not pay attention to the three key dates mentioned above. Most importantly, don’t buy a stock just for its dividend. Dividend paying companies are usually mature companies that can no longer reinvest their profits into the business to earn a sufficient return required by their shareholders.
You should have a diversified portfolio that includes both dividend and growth oriented companies. Have a financial question? Contact ACap Asset Management at or 818-272-8511. Ara Oghoorian, CFA, CFP® is the president and founder of ACap Asset Management, Inc., a “Fee-Only” investment management firm headquarted in Los Angeles, CA specializing in helping doctors and healthcare professionals make sound financial decisions.
Visit us at : 3 Dates to Remember if You Want A Cash Dividend – ACap Advisors & Accountants
What happens to GE shares after split?
Did General Electric perform a stock split? – GE will will split its business into three standalone companies. This will not result in a stock split. Instead, shareholders of GE will receive a certain number of shares in the newly created companies once the spin-off is completed.
What happened to GE HealthCare?
21st century – In 2001, GE Medical Systems acquired San Francisco, CA, based CT maker Imatron, Inc for $210 million. Imatron produced an Electron beam tomography (EBT) scanner that performs imaging applications used by physicians specializing in cardiology, pulmonology and gastroenterology.
- The formal Imatron business was later incorporated into GE HealthCare’s Diagnostic Imaging business segment.
- In early 2002, GE HealthCare had acquired MedicaLogic (creator of the former Logician, an ambulatory Electronic Medical Records system) for approximately $32 million.
- By Jan 2003, GE acquired Millbrook Corporation, maker of Millbrook Practice Manager, a billing and scheduling system for doctors’ offices.
GE HealthCare IT would later merge the two products into one, although the stand-alone EMR product is still available and in development. Also in April 2002, GE HealthCare completed the acquisition of Visualization Technology, Inc., Boston, MA; a manufacturer of intra-operative medical devices and related products for use in minimally invasive image guided surgery.
- In 2003, GE HealthCare acquired Instrumentarium (including its Datex-Ohmeda division), a producer, manufacturer, and supplier of anesthesia machines and mechanical ventilators.
- To satisfy regulatory concerns in the United States and in Europe, GE HealthCare was forced to divest Instrumentarium’s Ziehm Imaging mobile C-arm business, as well as its Spacelabs patient-monitoring unit.
Currently, GE HealthCare owns 80% of all anesthesia machines in the United States and 60% of the machines in the world. The former Instrumentarium business was incorporated into GE HealthCare’s Clinical Systems business segment. Packaging radioactive pharmaceuticals at GE HealthCare’s facility in Amersham, England In 2004, the former Amersham plc business segments were separated into the GE HealthCare Medical Diagnostics and Life Sciences business segments and 1 May 2013, both the business were combined again under the GE Life Sciences brand with Kieran Murphy taking the leadership role.
Also in 2004, GE HealthCare along with other healthcare companies built a research reactor for neutron and unit cell research at GE’s European Research Center near Garching (outside of Munich ), Germany, It is the only such reactor currently in operation. In 2005, Sir William Castell, CEO of GE HealthCare and former CEO of Amersham plc stepped down as CEO to become Chairman of the Wellcome Trust —a charity that fosters and promotes human and animal research—in the United Kingdom.
Former GE Medical Systems CEO Joe Hogan became the overall CEO for the GE HealthCare business. In 2005, Dental Imaging operations were separated from GE HealthCare. The PaloDEx Group Oy was founded and continues the business with its subsidiaries Instrumentarium Dental and SOREDEX.
- Specifically, Instrumentarium Dental continues the brands Orthopantomograph and intraoral systems FOCUS and SIGMA, formerly known as Instrumentarium Imaging or GE HealthCare products.
- In September 2005, GE HealthCare and IDX Systems Corporation announced that they entered into a definitive, $1.2 billion merger agreement for GE to acquire IDX, a leading healthcare information technology (IT) provider.
The acquisition was completed in January 2006. IDX was folded into GE HealthCare Integrated IT Solutions, which specializes in clinical information systems and healthcare revenue management. On 4 February 2008, GE HealthCare announced that it had completed the acquisition of Whatman plc (LSE:WHM), a global supplier of filtration products and technologies at 270p per share in cash for each Whatman share, valuing Whatman at approximately £363 million (approximately $713 million.) In July 2008, Joseph Hogan announced his intent to leave his post as CEO of GE HealthCare to take the role of CEO at ABB,
- On July 17, 2008, GE HealthCare announced John Dineen had been chosen to replace outgoing CEO Joseph Hogan. Mr.
- Dineen had been head of GE’s Transportation division since 2005.
- On March 24, 2010, GE HealthCare announced acquisition of MedPlexus.
- In late April, 2010, GE HealthCare announced it was investing €3 million in the Technology Research for Independent Living Centre (TRIL).
The Irish centre seeks to enhance independence for elderly people through technological innovation. In July 2015, GE HealthCare partnered with the 2015 CrossFit Games to provide athletes with mobile imaging equipment. In January 2016, it was announced GE HealthCare’s global headquarters will move to Chicago effective early 2016.
- In June 2017, GE announced Kieran Murphy as the new CEO of GE HealthCare, with former CEO John Flannery ‘s appointment as CEO of GE.
- In April 2018, GE announced the sale of several healthcare information technology assets for $1.05 billion to Veritas Capital,
- In June 2018, GE announced plans to spin off GE HealthCare into its own company, representing the conglomerate’s efforts to shrink and focus more on the aviation, power and renewable energy sectors.
The plan was put on hold after selling the biopharma business to Danaher Corporation for $21.4 billion. In January 2020, GE announced Mahesh Palashikar As New President, CEO of its south Asia division. In November of the same year the business announced it would acquire Prismatic Sensors AB,
In 2021, GE started a collaboration with Spectronic Medical to create AI-based software. In September the business announced it would acquire BK Medical from Altaris Capital Partners for $1.45 billion. On November 9, 2021, the company announced it would demerge into three investment-grade public companies, GE HealthCare being one of the three planned divestitures.
The spin-off of GE HealthCare happened on 4 January 2023. In February 2023, it was announced GE HealthCare has acquired the San Mateo -headquartered AI medical technology manufacturer, Caption Health, for an undisclosed sum.
Who is the biggest competitor for GE HealthCare?
GEHC vs. HOLX, PHG, SGEN, CNC, ALC, IDXX, RMD, ABC, HLN, and ILMN – Should you be buying GE HealthCare Technologies stock or one of its competitors? The main competitors of GE HealthCare Technologies include Hologic (HOLX), Koninklijke Philips (PHG), Seagen (SGEN), Centene (CNC), Alcon (ALC), IDEXX Laboratories (IDXX), ResMed (RMD), AmerisourceBergen (ABC), Haleon (HLN), and Illumina (ILMN).
How many shares of GE HealthCare will I get?
Exhibit 99.1 Press Release GE Board of Directors Approves Separation of GE HealthCare
| • | Board sets GE HealthCare distribution date of January 3, 2023, after market close |
table>
table>
BOSTON – November 30, 2022 – General Electric Company (“GE”) (NYSE: GE) announced today that its Board of Directors has approved the previously announced spin-off of its healthcare business, GE Healthcare Holding LLC (“GE HealthCare”). Prior to such spin-off, GE HealthCare is expected to be converted into a corporation and renamed GE HealthCare Technologies Inc.
The company is expected to begin trading on Nasdaq on January 4, 2023, under the ticker “GEHC”. To effect the separation, GE’s Board of Directors approved a distribution to GE shareholders of at least 80.1% of the outstanding shares of GE HealthCare. Holders of GE common stock will be entitled to receive one share of GE HealthCare common stock for every three shares of GE common stock held on December 16, 2022, the record date for the distribution.
The distribution is expected to occur after U.S. market close on January 3, 2023. For U.S. federal income tax purposes, the distribution will be conducted in a tax-efficient manner for GE shareholders in the United States. The distribution is subject to certain conditions described in the registration statement on Form 10 filed by GE HealthCare.
GE Chairman and CEO, GE Aerospace CEO, H. Lawrence Culp, Jr. said, “Today’s announcement marks one of the final milestones for our planned spin-off of GE HealthCare as we move toward launching three independent, industry-leading, and investment-grade companies. GE Healthcare is driving precision care globally, with a clear strategy for value creation that will benefit patients, customers, and shareholders under the leadership of CEO Peter Arduini and his team.” Effective upon the spin-off, GE will retain up to 19.9% of the outstanding shares of GE HealthCare common stock.
GE shareholders do not need to take any action to receive shares of GE HealthCare common stock to which they are entitled as a GE shareholder. Additionally, shareholders do not need to pay any consideration, or surrender or exchange shares of GE common stock, to participate in the separation.
GE HealthCare Investor Day As previously announced, GE HealthCare will host an investor day on Thursday, December 8, 2022, in New York, NY. GE HealthCare’s management team will present its growth strategies and a showcase of its innovative solutions. Investors, media, and members of the general public are invited to learn more about the pending spin-off at https://www.ge.com/investor-relations/spinoff-resources.
Future updates to the Form 10 will be filed with the SEC and may be viewed at www.sec.gov as filings under GE HealthCare’s current name, GE Healthcare Holding LLC. The Form 10 filed on November 18, 2022, is subject to change and will be made final prior to the effective date.
- Forward-Looking and Cautionary Statements This announcement contains forward-looking statements – that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain.
- For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, including our success in executing and completing asset dispositions or other transactions, including our planned spin-offs of GE HealthCare and our portfolio of energy businesses that are planned to be combined as GE Vernova (Renewable Energy, Power, Digital and Energy Financial Services), and sales of our equity interests in Baker Hughes Company (Baker Hughes) and AerCap Holdings N.V.
(AerCap) and our expected equity interest in GE HealthCare after its spin-off, the timing of closing for such transactions, the ability to satisfy closing conditions, and the expected proceeds, consideration and benefits to GE; changes in macroeconomic and market conditions and market volatility, including impacts related to the COVID-19 pandemic, risk of recession, inflation, supply chain constraints or disruptions, rising interest rates, the value of securities and other financial assets (including our equity ownership positions in Baker Hughes and AerCap, and expected equity interest in GE HealthCare after its spin-off), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our business operations, financial results and financial position; and our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the capital structures of the three public companies that we plan to form from our businesses, the timing and amount of dividends, share repurchases, organic investments, and other priorities, see https://www.ge.com/investor-relations/important-forward-looking-statement-information, as well as our SEC filings.
We do not undertake to update our forward-looking statements. About GE GE (NYSE:GE) rises to the challenge of building a world that works. For more than 130 years, GE has invented the future of industry, and today the company’s dedicated team, leading technology, and global reach and capabilities help the world work more safely, efficiently, and reliably.
GE’s people are diverse and dedicated, operating with the highest level of integrity and focus to fulfill GE’s mission and deliver for its customers. www.ge.com About GE HealthCare GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator.
GE HealthCare employs approximately 51,000 people dedicated to creating a world where healthcare has no limits. GE HealthCare’s products, services, and solutions enable clinicians to make more informed decisions quickly and efficiently, improving patient care from diagnosis to therapy to monitoring. GE HealthCare’s products are used in more than two billion procedures to care for more than one billion patients annually, with a global installed base of more than four million medical devices and delivered over 100 million doses of imaging agents used in patient procedures in 2021.
www.gehealthcare.com Contact GE Investor Contact: Steve Winoker, 617.443.3400 [email protected] GE Media Contact: Whitney Mercer, 857.303.3079 [email protected] GE HealthCare Investor Contact: Carolynne Borders, 631.662.4317 [email protected]
What is the dividend declared by GE shipping?
Current Dividend Yield: 3.88% Annual dividend payment: ₹25.2.
How often does GD pay dividends?
Regular payouts for GD are paid quarterly.
Does GE pay monthly dividends?
General Electric Company (GE) Dividend History, Dates & Yield GE has a dividend yield of 0.27% and paid $0.27 per share in the past year. The dividend is paid every three months and the last ex-dividend date was Mar 6, 2023. Ex-Dividend Date Mar 6, 2023 Payout Frequency Quarterly Dividend Growth (1Y) 7.00%
| Ex-Div idend Date | Cash Amount | Record Date | Pay Date |
|---|---|---|---|
| Mar 6, 2023 | $0.080 | Mar 7, 2023 | Apr 25, 2023 |
| Dec 14, 2022 | $0.0625 | Dec 15, 2022 | Jan 25, 2023 |
| Sep 26, 2022 | $0.0625 | Sep 27, 2022 | Oct 25, 2022 |
| Jun 27, 2022 | $0.0625 | Jun 28, 2022 | Jul 25, 2022 |
| Mar 7, 2022 | $0.0625 | Mar 8, 2022 | Apr 25, 2022 |
| Dec 20, 2021 | $0.0625 | Dec 21, 2021 | Jan 25, 2022 |
| Sep 24, 2021 | $0.0625 | Sep 27, 2021 | Oct 25, 2021 |
| Jun 25, 2021 | $0.0625 | Jun 28, 2021 | Jul 26, 2021 |
| Mar 5, 2021 | $0.0625 | Mar 8, 2021 | Apr 26, 2021 |
| Dec 18, 2020 | $0.0625 | Dec 21, 2020 | Jan 25, 2021 |
| Sep 25, 2020 | $0.0625 | Sep 28, 2020 | Oct 26, 2020 |
| Jun 26, 2020 | $0.0625 | Jun 29, 2020 | Jul 27, 2020 |
| Mar 6, 2020 | $0.0625 | Mar 9, 2020 | Apr 27, 2020 |
| Dec 20, 2019 | $0.0625 | Dec 23, 2019 | Jan 27, 2020 |
| Sep 13, 2019 | $0.0625 | Sep 16, 2019 | Oct 25, 2019 |
| Jun 28, 2019 | $0.0625 | Jul 1, 2019 | Jul 25, 2019 |
| Mar 8, 2019 | $0.0625 | Mar 11, 2019 | Apr 25, 2019 |
| Dec 19, 2018 | $0.0625 | Dec 20, 2018 | Jan 25, 2019 |
| Sep 14, 2018 | $0.7494 | Sep 17, 2018 | Oct 25, 2018 |
| Jun 15, 2018 | $0.7494 | Jun 18, 2018 | Jul 25, 2018 |
| Feb 23, 2018 | $0.7494 | Feb 26, 2018 | Apr 25, 2018 |
| Dec 26, 2017 | $0.7494 | Dec 27, 2017 | Jan 25, 2018 |
| Sep 15, 2017 | $1.4988 | Sep 18, 2017 | Oct 25, 2017 |
| Jun 15, 2017 | $1.4988 | Jun 19, 2017 | Jul 25, 2017 |
| Feb 23, 2017 | $1.4988 | Feb 27, 2017 | Apr 25, 2017 |
| Dec 22, 2016 | $1.4988 | Dec 27, 2016 | Jan 25, 2017 |
| Sep 15, 2016 | $1.4364 | Sep 19, 2016 | Oct 25, 2016 |
| Jun 16, 2016 | $1.4364 | Jun 20, 2016 | Jul 25, 2016 |
| Feb 25, 2016 | $1.4364 | Feb 29, 2016 | Apr 25, 2016 |
| Dec 17, 2015 | $1.4364 | Dec 21, 2015 | Jan 25, 2016 |
| Sep 17, 2015 | $1.4364 | Sep 21, 2015 | Oct 26, 2015 |
| Jun 18, 2015 | $1.4364 | Jun 22, 2015 | Jul 27, 2015 |
| Feb 19, 2015 | $1.4364 | Feb 23, 2015 | Apr 27, 2015 |
| Dec 18, 2014 | $1.4364 | Dec 22, 2014 | Jan 26, 2015 |
| Sep 18, 2014 | $1.3739 | Sep 22, 2014 | Oct 27, 2014 |
| Jun 19, 2014 | $1.3739 | Jun 23, 2014 | Jul 25, 2014 |
| Feb 20, 2014 | $1.3739 | Feb 24, 2014 | Apr 25, 2014 |
| Dec 19, 2013 | $1.3739 | Dec 23, 2013 | Jan 27, 2014 |
| Sep 19, 2013 | $1.1866 | Sep 23, 2013 | Oct 25, 2013 |
Dividend amounts are adjusted for stock splits when applicable. : General Electric Company (GE) Dividend History, Dates & Yield